Evidence map›Paper›PMID 36142155›Full record

ArticleInternational journal of molecular sciences2022

Molasses-Silver Nanoparticles: Synthesis, Optimization, Characterization, and Antibiofilm Activity.

Rabab A Dorgham, Mohamed N Abd Al Moaty, Khim Phin Chong, Bassma H Elwakil

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Antibiofilm activity of silver nanoparticles against Candida sp. isolated from the oral cavity.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2025
    Article
  4. Review
  5. Article
  6. Nanoemulsion ofMolecules (Basel, Switzerland) · 2023
    Article
  7. ACS omega · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Rabab A DorghamBotany and Microbiology Department, Faculty of Science, Alexandria University, Alexandria 21568, Egypt.
Mohamed N Abd Al MoatyChemistry Department, Faculty of Science, Alexandria University, Alexandria 21568, Egypt.ORCID 0000-0003-2843-9704
Khim Phin ChongFaculty of Science and Natural Resources, Universiti Malaysia Sabah, Jalan UMS, Kota Kinabalu 88400, Sabah, Malaysia.ORCID 0000-0002-5143-7283
Bassma H ElwakilDepartment of Medical Laboratory Technology, Faculty of Applied Health Sciences Technology, Pharos University in Alexandria, Alexandria 21321, Egypt.ORCID 0000-0001-6596-3156
Alexandria University · EGPharos University in Alexandria · EGUniversiti of Malaysia Sabah · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biofilms are matrix-enclosed communities of bacteria that are highly resistant to antibiotics. Adding nanomaterials with antibacterial activity to the implant surfaces may be a great solution against biofilm formation. Due to its potent and widespread antibacterial effect, silver nanoparticles were considered the most potent agent with different biological activities. In the present investigation, silver nanoparticles (AgNPs) were newly synthesized as antibiofilm agents using sugarcane process byproduct (molasses) and named Mo-capped AgNPs. The synthesized nanoparticles showed promising antimicrobial activity against

Indexed as

Metal NanoparticlesSilverAnti-Bacterial AgentsBiofilmsCandida albicansMicrobial Sensitivity TestsMolassesPlant ExtractsSpectroscopy, Fourier Transform InfraredStaphylococcus aureusAnti-Bacterial AgentsPlant ExtractsSilverantibiofilmgreen silver nanoparticlesresponse surface methodology

Identifiers

PMID36142155
PMCPMC9499626
OpenAlexW4295064462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.